23
September
2021
|
11:15
Europe/London

CEAS spin-out Holiferm lands $7m investment

A spin-out company created by an academic and former PhD researcher in the Department of Chemical Engineering and Analytical Science (CEAS) has received a $7 million (£5.1 million) investment boost.

Holiferm stemmed from research within The University of Manchester, with current CEAS academic James Winterburn and former CEAS PhD researcher Ben Dolman working to invent the technology involved in its continual fermentation processes for the manufacture of biosurfactants – a greener alternative to surfactants for use in environmentally-friendly home and personal care products.

The company will use this investment to build a commercial biosurfactant plant, allowing it to elevate its work in the biosurfactant space, and bring this to market at a competitive price point.

More details on Holiferm's investment can be found on the company's website.

This $7 million investment boost will enable Holiferm to build a world-leading biosurfactant manufacturing facility and fully commercialise its sustainable manufacturing process.
Ben Dolman, Holiferm CEO, and former CEAS researcher

Share this release

Share on: Twitter
Share on: Facebook
Share on: LinkedIn